Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Hims & Hers Health

Tracked across 7 events · 729 articles · First seen Jun 26, 2025 · Last active Sep 22, 2026

Sentiment
-17
Attention
8
Events
7
Relationships
10
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 -70
Regulatory
Impact: Hims & Hers Health dropped its plan to offer a compounded version of Wegovy after the FDA threatened action, leading to a 14% drop in its stock. This decision impacts its strategy in the weight-loss medication market.
Feb 07, 2026 · 6 articles
4 -60
Regulatory
Hims & Hers Health, Inc. and certain executives face a securities fraud class action lawsuit filed in the Northern District of United States — California (Velanki v. Hims & Hers Health, Inc., No. 26-cv-09313). The…
Impact: Hims & Hers is the central defendant in the securities class action and the FTC lawsuit, facing allegations of deceptive practices that have already caused a significant stock drop and reputational damage. The outcome could result in financial penalties and changes to its business operations.
Jul 29, 2026 · 215 articles
6 20
Business
Impact: Hims & Hers Health launched a cheaper, off-brand version of Semaglutide, capitalizing on the demand for GLP-1 drugs, which led to legal threats from Novo Nordisk.
Feb 05, 2026 · 6 articles
6 10
Business
Impact: Hims & Hers Health is advertising its GLP-1 weight loss drugs, emphasizing access to healthcare, and participating in the health and telehealth advertising trend.
Feb 04, 2026 · 6 articles
8 -20
International
Impact: Hims & Hers Health reported a wider loss, but is not central.
Apr 08, 2026 · 416 articles
4 0
Business
Impact: Hims & Hers Health is mentioned as a past Zacks pick, but is not directly related to this event.
Jul 16, 2026 · 74 articles
2 0
Business
Gap Inc. announced the appointment of Kirsten Green, founder and managing partner of venture capital firm Forerunner, to its board of directors, effective immediately. The appointment was announced on September 15, 2026. Green brings more…
Impact: Hims & Hers Health is cited as one of the companies in Forerunner's portfolio, mentioned as part of Kirsten Green's investment track record.
Sep 15, 2026 · 6 articles
85 Hims & Hers Health shared health informationHims & Hers Securities...
75 Hims & Hers Health lost market capitalizationHims & Hers Securities...
+ 35 more actions View on Dashboard
Novo Nordisk competitor ↔ Hims & Hers Health Hims & Hers Health is facing legal threats from Novo Nordisk after their brief d
Novo Nordisk competitor ↔ Hims & Hers Health Novo Nordisk terminated its distribution partnership with Hims & Hers Health and
Snap Inc. ↔ Hims & Hers Health
Snap Inc. ↔ Hims & Hers Health
Meta Platforms ↔ Hims & Hers Health
Meta Platforms ↔ Hims & Hers Health
ERGEN INTELLIGENCE
Track Hims & Hers Health live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.